The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies

被引：1

作者：

Ren, Jiaqi ^{[1
,2
]}

Lv, Linlin ^{[1
]}

Tao, Xufeng ^{[1
]}

Zhai, Xiaohan ^{[1
]}

Chen, Xuyang ^{[1
]}

Yu, Hao ^{[1
,2
]}

Zhao, Xinya ^{[1
,2
]}

Kong, Xin ^{[1
,2
]}

Yu, Zhan ^{[1
]}

Dong, Deshi ^{[1
]}

Liu, Jing ^{[3
]}

机构：

[1] Dalian Med Univ, Dept Pharm, Affiliated Hosp 1, Dalian, Peoples R China

[2] Dalian Med Univ, Sch Pharm, Dalian, Peoples R China

[3] Dalian Med Univ, Affiliated Hosp 1, Stem Cell Clin Res Ctr, Natl Joint Engn Lab, Dalian, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷

关键词：

CBL; cancer; E3 ubiquitin ligase; targeted therapy; immunotherapy; GROWTH-FACTOR RECEPTOR; TRAIL-INDUCED APOPTOSIS; CELL LUNG-CANCER; SMALL-MOLECULE INHIBITOR; C-CBL; GASTRIC-CANCER; PROSTATE-CANCER; TYROSINE KINASE; DOWN-REGULATION; E3; LIGASE;

D O I：

10.3389/fphar.2024.1432545

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The CBL (Casitas B-lineage lymphoma) family, as a class of ubiquitin ligases, can regulate signal transduction and activate receptor tyrosine kinases through various tyrosine kinase-dependent pathways. There are three members of the family: c-CBL, CBL-b, and CBL-c. Numerous studies have demonstrated the important role of CBL in various cellular pathways, particularly those involved in the occurrence and progression of cancer, hematopoietic development, and regulation of T cell receptors. Therefore, the purpose of this review is to comprehensively summarize the function and regulatory role of CBL family proteins in different human tumors, as well as the progress of drug research targeting CBL family, so as to provide a broader clinical measurement strategy for the treatment of tumors.

引用

页数：24

共 50 条

[1] An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance
Mohapatra, Bhopal
Zutshi, Neha
An, Wei
Goetz, Benjamin
Arya, Priyanka
Bielecki, Timothy A.
Mustaq, Insha
Storck, Matthew D.
Meza, Jane L.
Band, Vimla
Band, Hamid
DEVELOPMENT, 2017, 144 (06): : 1072 - 1086
[2] Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity
Denise L. Gay
Hilda Ramón
Paula M. Oliver
Immunologic Research, 2008, 42 : 51 - 64
[3] Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity
Gay, Denise L.
Ramon, Hilda
Oliver, Paula M.
IMMUNOLOGIC RESEARCH, 2008, 42 (1-3) : 51 - 64
[4] The Cbl family and other ubiquitin ligases: Destructive forces in control of antigen receptor signaling
Duan, L
Reddi, AL
Ghosh, A
Dimri, M
Band, H
IMMUNITY, 2004, 21 (01) : 7 - 17
[5] Regulating the regulator: negative regulation of Cbl ubiquitin ligases
Ryan, PE
Davies, GC
Nau, MM
Lipkowitz, S
TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (02) : 79 - 88
[6] On ubiquitin ligases and cancer
Beckmann, JS
Maurer, F
Delorenzi, M
Falquet, L
HUMAN MUTATION, 2005, 25 (06) : 507 - 512
[7] The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system
Rao, N
Dodge, I
Band, H
JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 71 (05) : 753 - 763
[8] Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases
Mohapatra, Bhopal
Ahmad, Gulzar
Nadeau, Scott
Zutshi, Neha
An, Wei
Scheffe, Sarah
Dong, Lin
Feng, Dan
Goetz, Benjamin
Arya, Priyanka
Bailey, Tameka A.
Palermo, Nicholas
Borgstahl, Gloria E. O.
Natarajan, Amarnath
Raja, Srikumar M.
Naramura, Mayumi
Band, Vimla
Band, Hamid
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (01): : 122 - 139
[9] Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy
Vriend, Jerry
CANCERS, 2023, 15 (13)
[10] The role of E3 ubiquitin ligases in the development and progression of glioblastoma
Luke M. Humphreys
Paul Smith
Zhuoyao Chen
Shahd Fouad
Vincenzo D’Angiolella
Cell Death & Differentiation, 2021, 28 : 522 - 537

← 1 2 3 4 5 →